On Friday, GeneDx Holdings Corp (NASDAQ: WGS) opened lower -7.19% from the last session, before settling in for the closing price of $73.73. Price fluctuations for WGS have ranged from $1.16 to $89.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 5.08% over the past five years. Company’s average yearly earnings per share was noted 93.74% at the time writing. With a float of $21.35 million, this company’s outstanding shares have now reached $25.98 million.
Let’s look at the performance matrix of the company that is accounted for 1000 employees. In terms of profitability, gross margin is 54.23%, operating margin of -20.43%, and the pretax margin is -31.52%.
GeneDx Holdings Corp (WGS) Insider Updates
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of GeneDx Holdings Corp is 25.84%, while institutional ownership is 66.98%. The most recent insider transaction that took place on Nov 15 ’24, was worth 3,180,000. Before that another transaction happened on Oct 31 ’24, when Company’s 10% Owner sold 865,800 for $75.00, making the entire transaction worth $64,935,000. This insider now owns 2,866,833 shares in total.
GeneDx Holdings Corp (WGS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 93.74% per share during the next fiscal year.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
Check out the current performance indicators for GeneDx Holdings Corp (WGS). In the past quarter, the stock posted a quick ratio of 2.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.17, a number that is poised to hit 0.11 in the next quarter and is forecasted to reach 0.49 in one year’s time.
Technical Analysis of GeneDx Holdings Corp (WGS)
GeneDx Holdings Corp (NASDAQ: WGS) saw its 5-day average volume 0.67 million, a positive change from its year-to-date volume of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 27.29%. Additionally, its Average True Range was 6.27.
During the past 100 days, GeneDx Holdings Corp’s (WGS) raw stochastic average was set at 67.79%, which indicates a significant increase from 17.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 180.72% in the past 14 days, which was higher than the 95.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $55.94, while its 200-day Moving Average is $29.13. Nevertheless, the first resistance level for the watch stands at $72.56 in the near term. At $76.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $78.96. If the price goes on to break the first support level at $66.16, it is likely to go to the next support level at $63.88. Assuming the price breaks the second support level, the third support level stands at $59.76.
GeneDx Holdings Corp (NASDAQ: WGS) Key Stats
There are currently 27,471K shares outstanding in the company with a market cap of 1.74 billion. Presently, the company’s annual sales total 202,570 K according to its annual income of -175,770 K. Last quarter, the company’s sales amounted to 76,870 K and its income totaled -8,310 K.
